---
trial_id: 721
discovery_date: 2022-04-24 16:23:21.290718
date: 2022-04-24 16:23:21.290718
title: "Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis"
summary: |
  <b>Conditions</b>:    Multiple Sclerosis;   Internuclear Ophthalmoplegia<br /><b>Interventions</b>:    Drug: Clemastine Fumarate;   Drug: Placebo<br /><b>Sponsor</b>:    Amsterdam UMC, location VUmc<br /><b>Not yet recruiting</b>
link: 'https://clinicaltrials.gov/ct2/show/NCT05338450?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14'
published_date: 2022-04-21 16:00:00
trial_source: ClinicalTrials.gov
relevant: 
options:
  unlisted: false
---
<b>Conditions</b>:    Multiple Sclerosis;   Internuclear Ophthalmoplegia<br /><b>Interventions</b>:    Drug: Clemastine Fumarate;   Drug: Placebo<br /><b>Sponsor</b>:    Amsterdam UMC, location VUmc<br /><b>Not yet recruiting</b>